Global Smart Inhalers Market Analysis & Trends - Industry Forecast to 2030
Smart Inhalers: Market Size
From $1350.81 million in 2024, the global Smart Inhalers market is projected to reach $21175.52 million by 2030. Based on our analysis the market is expected to grow at a CAGR of 59.2% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing include increased focus towards advanced treatment protocols, increase in air pollution, and rising prevalence of respiratory diseases.
Global Smart Inhalers Market: Market Dynamics
The rise in the levels of pollution globally which has resulted in the increase of population susceptible to chronic obstructive pulmonary diseases acts as the vital factor escalating the market growth, also growing prevalence of chronic obstructive pulmonary diseases (COPD) and asthma, increase in population susceptibility to indoor air pollutants, increasing collaboration between pharma and digital health companies and rising prevalence of respiratory diseases are the major factors among others driving the smart inhalers market.
Connected inhalers are benefitted from the diminishment of flow sensors to evaluate the volume of medication inhaled. For instance, a Switzerland-based company, Sensirion, has developed SDP3x which is a differential pressure sensor, which can be integrated into smart inhalers. Miniaturization also allows the development of systems, making them furthermore user-friendly.
On the other hand, high cost associated with the development of smart inhalers is likely to obstruct the profit boundaries. In addition, rising focus towards advanced treatment protocols and rising R&D activities will further boost the smart inhalers market.
Impact of COVID-19 on Smart Inhalers
The sudden outrage of the COVID-19 pandemic is a unique global public health emergency declared by the World Health Organization (WHO). The COVID-19 shows a positive impact on the smart inhalers market. The patients infected with the coronavirus who also have respiratory problems have experienced chronic illnesses such as asthma. This particular aspect has created acceleration for the smart inhalers market. The outbreak of COVID-19 is predictable to grow the command for smart inhalers due to the increasing demand for an effective device to keep a check on the oxygen level among the COVID infected population.
By Application
Asthma Segment Dominate the Market in 2024
The asthma segment made huge revenue in 2024 and growing its prominence during the forecast period owing to the rise in prevalence of people suffering from respiratory diseases such as asthma among bronchitis, and other chronic obstructive pulmonary diseases. Furthermore, asthma is one of the most widely occurring chronic inflammatory diseases.
By Geography
Asia Pacific Region is Leading in the Global Market Place
The Asia Pacific is likely to have a huge demand in the forecast period due to the rapid development of the healthcare infrastructure and the ongoing technical development. Furthermore, economic expansion and industrialization are projected to be some salient causes that can augment the regional market during the forecast period. In addition, India and China are predicted to make a major contribution to developing the regional market owing to the mounting investments in the regions.
List of the Key Players Profiled in the Market Include: • AstraZeneca PLC
• Boehringer Ingelheim Group
• Adherium Limited
• GlaxoSmithKline Plc
• Cohero Health, Inc.
• Novartis International AG
• OPKO Health, Inc
• Teva Pharmaceutical Industries Limited
• Vectura Group Plc
• Propeller Health
List of the Regions/Countries Profiled in the Market Include: North America
• US
• Canada
• Mexico
Europe
• Germany
• U.K
• Italy
• France
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• New Zealand
• Rest of Asia Pacific
Middle East
• Saudi Arabia
• UAE
• Rest of Middle East
Latin America
• Argentina
• Brazil
• Rest of Latin America
Rest of the World (RoW)
• South Africa
• Others